[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Advances While Market Declines: Some Information for Investors",
    "summary": "Amgen (AMGN) closed at $262.05 in the latest trading session, marking a +1.34% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=f3810436a2ce571827800dcf6645636f78ec42c1c9f4a07f1d5c37845dea633e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736290221,
      "headline": "Amgen (AMGN) Advances While Market Declines: Some Information for Investors",
      "id": 132309560,
      "image": "https://s.yimg.com/ny/api/res/1.2/gZA5XMnsr1RRZw6lGNAcdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NDA-/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) closed at $262.05 in the latest trading session, marking a +1.34% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=f3810436a2ce571827800dcf6645636f78ec42c1c9f4a07f1d5c37845dea633e"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=90f15c57730d67bc414d708aa3cbf7c4a3b7892e22a3851318b78c88fcff6fd6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736268000,
      "headline": "Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 132324423,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=90f15c57730d67bc414d708aa3cbf7c4a3b7892e22a3851318b78c88fcff6fd6"
    }
  },
  {
    "ts": null,
    "headline": "How to Find Strong Medical Stocks Slated for Positive Earnings Surprises",
    "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
    "url": "https://finnhub.io/api/news?id=5dff30ec16cb3e0ec268389dd35eb04203726857cd8d560a11dae6b194ddad57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736258413,
      "headline": "How to Find Strong Medical Stocks Slated for Positive Earnings Surprises",
      "id": 132301291,
      "image": "https://media.zenfs.com/en/zacks.com/8442d24e11d454aa89061259a9714d43",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
      "url": "https://finnhub.io/api/news?id=5dff30ec16cb3e0ec268389dd35eb04203726857cd8d560a11dae6b194ddad57"
    }
  },
  {
    "ts": null,
    "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
    "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
    "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736249479,
      "headline": "Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)",
      "id": 132302431,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1403479106/image_1403479106.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects for 2025.",
      "url": "https://finnhub.io/api/news?id=f1588fec1459d5307c6fb14d2a4090f5abed15b46fc8ab0d4ba8d1e2024cdad0"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR",
    "summary": "Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR are part of the Zacks top Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=8f23e9ddc0f246271a53d18f40e3764d84f7be88000a70bba4abee574f97afb8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736247480,
      "headline": "The Zacks Analyst Blog Highlights Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR",
      "id": 132299252,
      "image": "https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR are part of the Zacks top Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=8f23e9ddc0f246271a53d18f40e3764d84f7be88000a70bba4abee574f97afb8"
    }
  }
]